Multi-imaging modality approach. Covadonga Fernández-Golfín Cardiac Imaging Unit. Cardiology Department. Ramón y Cajal Hospital.

Similar documents
Aortic Regurgitation & Aorta Evaluation

What s New in Cardiac MRI

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

Cardiac MRI in ACHD What We. ACHD Patients

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Organic mitral regurgitation

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

Policy #: 222 Latest Review Date: March 2009

New Imaging for Aortic Valve Disease. Anthony DeMaria Judy and Jack White Chair Director, Sulpizio CV Center University of California, San Diego

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

How to Assess and Treat Obstructive Lesions

Comprehensive Echo Assessment of Aortic Stenosis

The new Guidelines: Focus on Chronic Heart Failure

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

When Does 3D Echo Make A Difference?

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Cardiac magnetic resonance imaging in rheumatoid arthritis: promising or misleading? Sophie Mavrogeni MD FESC

Pushing the limits of cardiac CT. Steven Dymarkowski Radiology / Medical Imaging Research Centre

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Current and Future Imaging Trends in Risk Stratification for CAD

Restrictive Cardiomyopathy

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Valvular Heart Disease

Asymptomatic Valvular Disease:

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Chapter 5 Section 1.1. Diagnostic Radiology (Diagnostic Imaging)

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Imaging. Prof Geneviève DERUMEAUX Hôpital Henri Mondor Créteil, FRANCE

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

I have no financial disclosures

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Paravalvular Regurgitation is a Risk Factor Following TAVI

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Spotlight on Valvular Heart Disease Guidelines

Conflict Disclosures. Vermont Cardiac Network. Outline. Series Learning Objectives 4/27/2016. Scott E. Friedman April 28, 2016

Imaging of the Heart Todd Tessendorf MD FACC

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Valvular Heart Disease. Dr. HANAN ALBACKR

Multimodality Imaging of Septal Defects

Rotation: Echocardiography: Transthoracic Echocardiography (TTE)

TAVR: Echo Measurements Pre, Post And Intra Procedure

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Understanding the guidelines for Interventions in MR. Ali AlMasood

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Ve V rmont rmon Card Car iac d Netw Ne ork tw Scott E. Friedman April 28, 2016

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease

General Cardiovascular Magnetic Resonance Imaging

New ASE Guidelines: What you must know

Section 1: Initial Evaluation for Valvular Heart Disease Table 1: Initial Evaluation of an Asymptomatic Patient

ρ = 4(νp)2 Scale -200 to 200 V = m/s Grad = 34 mmhg V = 1.9 m/s Grad = 14 mmhg Types

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

When Should I Order a Stress Test or an Echocardiogram

Hypertension in Aortic Valve Disease

Athlete s Heart vs. Cardiomyopathy

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

The Role of Imaging in Transcatheter Aortic Valve Implantation

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Low Gradient Severe AS: Who Qualifies for TAVR? Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor

Course Learning Objectives Sunday, February 17 Friday, February 22

Valvular disease : Ο ρόλος του CMR. Sophie Mavrogeni MD FESC. Onassis Cardiac Surgery Center Athens Greece

Cardiovascular Imaging Endpoints in Oncology Clinical Trials

Current Indications for Cardiac MRI: What You See is What You Get?

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

Chapter 5 Section 1.1

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Aortic stenosis aetiology: morphology of calcific AS,

Mitral Valve Reference Center. Ariana González Gómez Heart Valve Clinic. University Hospital Ramón y Cajal. Madrid. Spain.

(Ann Thorac Surg 2008;85:845 53)

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Valvular Guidelines: The Past, the Present, the Future

Covered Indications. Evaluation of chest pain syndrome uninterpretable or equivocal stress test (exercise, perfusion, or stress echo)

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Aortic regurgitation. Physiopathology. Dr Pilar Tornos Hospital Vall d Hebron. Barcelona Eurovalve 2014

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

tomtec arena Quality

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

My Patient Needs a Stress Test

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

Multimodality Imaging of the Thoracic Aorta

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Investigations in valvular heart disease

Valvular Imaging Optimizing Data Acquisition and Interpretation

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Quantification of Aortic Regurgitation

IMAGING the AORTA. Mirvat Alasnag FACP, FSCAI, FSCCT, FASE June 1 st, 2011

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Vinod H. Thourani, MD

ARRHYTHMIAS AND DEVICE THERAPY

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Balloon mitral valvuloplasty

Transcription:

Multi-imaging modality approach Covadonga Fernández-Golfín Cardiac Imaging Unit. Cardiology Department. Ramón y Cajal Hospital.Madrid

Faculty Disclosure Covadonga Fernández-Golfín I have no financial relationships to disclose.

Valvular heart disease (VHD) Increase morbidity and mortality Early detection to improve prognosis Imaging techniques Diagnosis Prognosis Follow-up ECHOCARDIOGRAPHY, cardiac magnetic resonance, computed tomography

Valvular heart disease (VHD) CMR 1. Selected cases fot severirity assessment (regurgitation) 2. LV and RV volumes and function CT 1. Selected cases for severity assessment (AS planimetry) 2. Rule out CHD 3. TAVI European Heart Journal (2012) 33, 2451 2496

VHD Multi-imaging approach Combination of complementary information from different imaging modalities to obtain the most accurate information regarding diagnosis or prognosis with clinical application

VHD Imaging ETIOLOGY MECHANISM SEVERITY IMPACT CMR CMR PROGNOSIS THERAPEUTIC APPROACH CMR CT, CMR ECHOCARDIOGRAPHY

VHD Imaging Echocardiography CMR Computed tomography Available Economic Unstable patiens No radiation Temporal resolution Experience and data 3D technology Exercice Acoustic window Experience Reproducibility Anatomical and temporal resolution Non invasive No radiation Tissue characterization Reproducibility Costs and avilability Expertice Contraindications Excellent anatomic information Coronary assessment Calcification 3D Radiation and contrast Poor temp. resol

VHD Echocardiography ETIOLOGY MECHANISM SEVERITY IMPACT First line imaging modality: screening Comprehnesive study TEE if needed Quantitate severity

VHD Echocardiography ETIOLOGY MECHANISM SEVERITY IMPACT 3D echo (TT and TEE)

VHD Echocardiography PROGNOSIS Speckle tracking, exercise echo, 3D

VHD Echocardiography THERAPEUTIC APPROACH 3D echo

VHD Echocardiography THERAPEUTIC APPROACH 3D echo

VHD Echo Full evaluation in most Systematic, quantitate, limitations of the technique depending on the type patient and pathology Incorporate new technology in VHD assessment

VHD CMR ETIOLOGY MECHANISM SEVERITY IMPACT

VHD CMR ETIOLOGY MECHANISM SEVERITY IMPACT Impact of VHD: LV and RV volumes, mass and EF Reproducibility for serial evaluation

VHD CMR ETIOLOGY MECHANISM SEVERITY IMPACT Assessment of great vessels and other possible associated conditions (aortic aneurism or CoA) in the same study

VHD CMR PROGNOSIS Non invasive focal LV fibrosis detection Early LV dysfunction diagnosis Prognosis impact T1 mapping sequences for difusse fibrosis detection Azevedo et al. J Am Coll Cardiol 2010;56:278 87

VHD CMR Non conclusive echocardiogram: etiology, mechanism, severity or impact Symptomatic patients with non severe VHD and normal LV function Asymptomatic patients, prognosis assessment and early intervention warranted

VHD CT Rule out coronary disease before valvular surgery Assessment of great vessels and other possible associated conditions (aortic aneurism or CoA) in the same study, endocarditis complications

VHD CT Valvular anatomy and degree of calcification Lesion severity Radiologi a. 2013;55(1):24-36

VHD CT LV and RV volume and mass assessment European Journal of Radiology 2012; 81: e598 e604

VHD CT THERAPEUTIC APPROACH Assessment pre TAVI, complications J Am Coll Cardiol Img 2013; 6:249 62

VHD CT Never performed to evaluate isolated Rule CHD before surgery, concomitant assessment of VHD and associated conditions TAVI procedure or certain valvular heart disease complication

VHD Multi-imaging AS INITIAL EVALUATION ECHOCARDIOGRAPHY: AV anatomy, AS severity, LV function, LVH, PSP, diastolic function FINAL DIAGNOSIS NO YES SYMPTOMATIC AVR TAVI CT rule out CHD TEE (2D, 3D AA) CT TEE (2D, 3D planimetry) CMR (2D planimetry, LV EF, volume) Stress echocardiography ASYMPTOMATIC PROGNOSIS LV strain, exercise echo CMR (fibrosis)

VHD Multi-imaging AR INITIAL EVALUATION ECHOCARDIOGRAPHY: AV anatomy, AR severity, LV diameters and function, PSP, diastolic function, 3D echo if available FINAL DIAGNOSIS YES SYMPTOMATIC AVR CT rule out CHD NO CMR (AR severity, LV EF, LV volume) TEE (AR severity, 2D, 3D) ASYMPTOMATIC PROGNOSIS LV strain CMR (fibrosis)

VHD Multi-imaging MS INITIAL EVALUATION ECHOCARDIOGRAPHY: MV anatomy, Wilkins score, MS severity, LV diameters and function,, PSP, 3D echo if available FINAL DIAGNOSIS YES SYMPTOMATIC MVR PMV CT rule out CHD NO TEE (MS severity, score, 2D, 3D) DISCORDANT ASYMPTOMATIC Exercise echo Follow up

VHD Multi-imaging MR INITIAL EVALUATION ECHOCARDIOGRAPHY: MV anatomy, MR severity, LV function and diameters, PSP. SYMPTOMATIC MVR CT rule out CHD FINAL DIAGNOSIS NO YES Repair Clip TEE (2D, 3D) TEE (2D, 3D) CMR (MR severity, LV EF, volume and scar) ASYMPTOMATIC PROGNOSIS LV strain, exercise echo

Conclusions Echocardiography remains the first line imaging modality in VHD Alternative imaging modalities are useful and add complementary information with clinical application in selected patients Further clinical data is needed before they can be incoporated in everyday clinical routine